A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR

Authors

  • P. SANDEEP
  • K. ILANGO

DOI:

https://doi.org/10.47750/pnr.2022.13.S09.026

Keywords:

Remdesivir, HPLC, LC/MS, UV-Visible spectroscopy, Fluorometry.

Abstract

Remdesivir is a prodrug that works by imitating the nucleoside adenosine. It is an antiviral medication that has been used to treat the coronavirus. Given the severity of the condition, the medicine is critical to the therapy and accompanying research. Remdesivir is extremely important as a medicinal dose form. Remdesivir has been used with other medications in the following combinations: Remdesivir and Dexamethasone, Remdesivir and Tocilizumab, and Remdesivir and Ivermectin. To aid future study, the paper also gives a simultaneous and comparative review of the analytical investigations published in the literature for a pharmacological estimate. The extensive literature searches turned up a plethora of study publications. A complete explanation of common, hyphenated, and unique ways of analysis is given. Remdesivir analytical quantification is provided using HPLC, LCMS, UV-Visible spectroscopy, and fluorescence.

Downloads

Published

2022-11-07

How to Cite

P. SANDEEP, & K. ILANGO. (2022). A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR. Journal of Pharmaceutical Negative Results, 217–225. https://doi.org/10.47750/pnr.2022.13.S09.026

Issue

Section

Articles